Nasal SARS-CoV-2 S-specific IgA antibody levels resulting from an infection were boosted by a subsequent infection and displayed significant variant-transcending neutralization capability against SARS-CoV-2 variants [26]. The gene discussed is CD79A; the disease is infection.